APPLIED MOLECULAR TRANSPORT (AMTI) Forecast, Price Target & Analyst Ratings

NASDAQ:AMTIUS03824M1099

Current stock price

0.263 USD
-0.04 (-14.3%)
At close:
0.2629 USD
0 (-0.04%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for APPLIED MOLECULAR TRANSPORT (AMTI).

Forecast Snapshot

Consensus Price Target

Price Target
$1.02
+ 287.83% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 7, 2024
Period
Q4 / 2023
EPS Estimate
-$0.52
Revenue Estimate

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$1.02
Upside
+ 287.83%
From current price of $0.26 to mean target of $1.02, Based on 6 analyst forecasts
Low
$1.01
Median
$1.02
High
$1.05

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for AMTI. The average price target is 1.02 USD. This implies a price increase of 287.83% is expected in the next year compared to the current price of 0.263.

Analyst Ratings & History

Current Analyst Ratings

AMTI Current Analyst RatingAMTI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

AMTI Historical Analyst RatingsAMTI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
AMTI was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about AMTI.
In the previous month the buy percentage consensus was at a similar level.
AMTI was analyzed by 6 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-03-28Chardan CapitalDowngrade Buy -> Neutral
2023-03-06Chardan CapitalReiterate Buy
2023-02-08JefferiesDowngrade Hold -> Underperform
2023-01-05B of A SecuritiesDowngrade Buy -> Underperform
2022-12-27SVB LeerinkDowngrade Outperform -> Market Perform
2022-12-23JMP SecuritiesDowngrade Market Outperform -> Market Perform
2022-12-02Chardan CapitalInitiate Buy
2022-11-08SVB LeerinkMaintains Outperform
2022-07-07JefferiesDowngrade Buy -> Hold
2022-05-20SVB LeerinkMaintains Outperform
2022-05-19JMP SecuritiesMaintains Market Outperform
2022-05-10SVB LeerinkMaintains Outperform
2021-03-17JMP SecuritiesInitiate Outperform
2021-02-22SVB LeerinkMaintains Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 7, 2024
Period
Q4 / 2023
EPS Estimate
-$0.52
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
10.31%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

AMTI is expected to report earnings on 3/7/2024. The consensus EPS estimate for the next earnings is -0.52 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates 2023 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
AMTI revenue by date.AMTI revenue by date.
N/AN/AN/AN/AN/A
186.06%
N/A
79.39%
N/A
50.39%
N/A
46.62%
EBITDA
YoY % growth
AMTI ebitda by date.AMTI ebitda by date.
-29.24M-27.58M
5.68%
-64.84M
-135.10%
-97.54M
-50.43%
-124.09M
-27.22%
N/A
51.35%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
AMTI ebit by date.AMTI ebit by date.
-29.87M-28.29M
5.29%
-66.68M
-135.70%
-100.79M
-51.15%
-127.22M
-26.22%
N/A
75.79%
N/A
-178.81%
N/A
17.58%
N/A
10.23%
N/A
27.45%
N/A
41.81%
N/A
99.24%
N/A
17,925.00%
Operating Margin
AMTI operating margin by date.AMTI operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
AMTI eps by date.AMTI eps by date.
N/AN/AN/A-2.66
20.67%
-3.26
-22.56%
N/A
70.28%
N/A
20.00%
N/A
-111.84%
N/A
51.55%
N/A
17.31%
N/A
27.91%
N/A
53.76%
N/A
144.19%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 23
EPS
Q2Q % growth
-0.52
10.31%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-20.706M
10.36%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AMTI Yearly Revenue VS EstimatesAMTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 50M 100M
AMTI Yearly EPS VS EstimatesAMTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
14.38%
EPS Next 5 Year
12.45%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

APPLIED MOLECULAR TRANSPORT / AMTI Forecast FAQ

What do analysts expect the price target to be for APPLIED MOLECULAR TRANSPORT (AMTI)?

6 analysts have analysed AMTI and the average price target is 1.02 USD. This implies a price increase of 287.83% is expected in the next year compared to the current price of 0.263.

What is the next earnings date for AMTI stock?

APPLIED MOLECULAR TRANSPORT (AMTI) will report earnings on 2024-03-07, after the market close.

What are the consensus estimates for APPLIED MOLECULAR TRANSPORT (AMTI) next earnings?

The consensus EPS estimate for the next earnings of APPLIED MOLECULAR TRANSPORT (AMTI) is -0.52 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for AMTI stock?

The number of analysts covering APPLIED MOLECULAR TRANSPORT (AMTI) is 6.